Price $200.90 |
Market Cap
21B
|
Sector Health Care |
Div. Growth
9.30%
|
|
P/E
184.5
|
P/B
3.48
|
P/S
4.22
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
70.8
|
Op. Cash Flow
806.3K
|
FCF
3.0
|
|
Op. Margin
5.90%
|
Net Margin
2.30%
|
ROE
2.00%
|
ROI
2.40%
|
|
ROA
1.10%
|
EPS Growth
-67.40%
|
Current Ratio
2.3
|
Debt/Equity
49.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $15.49 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.44 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.27 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.13 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
